SCHEMBL23977983

SCHEMBL23977983

CSc1ccc(NC(=O)Nc2ccc(C#N)nc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 1/20 0.55
AR P10275 1/20 0.51
MAPT P10636 6/20 0.50
RAB9A P51151 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
NPC1 O15118 3/20 0.50
TP53 P04637 2/20 0.50
GBA1 P04062 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C19 P33261 1/20 0.50
KCNQ3 O43525 1/20 0.48
KCNQ2 O43526 1/20 0.48
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
KDM4E B2RXH2 2/20 0.45
CHEK1 O14757 2/20 0.44
LMNA P02545 4/20 0.42
POLB P06746 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23977676 0.80 RAB9A (0.58) NOX1MAPTRAB9ASMN1; SMN2NPC1
SCHEMBL23977677 0.77 RAB9A (0.53) NOX1MAPTRAB9ASMN1; SMN2NPC1
SCHEMBL31680457 0.77 AR (0.59) ARMAPTRAB9ASMN1; SMN2CYP1A2
SCHEMBL13036452 0.77 AR (0.59) ARMAPTRAB9ASMN1; SMN2CYP1A2
SCHEMBL3305812 0.76 AR (0.57) ARKCNQ3KCNQ2CHEK1MAPK1
SCHEMBL561583 0.75 CHEK1 (0.36) ARMAPTKCNQ3KCNQ2KDM4E
SCHEMBL31129270 0.75 AR (0.57) ARMAPTRAB9ASMN1; SMN2NPC1
SCHEMBL20942380 0.74 AR (0.59) ARMAPTSMN1; SMN2KCNQ3KCNQ2
SCHEMBL19776339 0.74 KCNQ3 (0.56) ARKCNQ3KCNQ2CHEK1
SCHEMBL3984197 0.74 AR (0.56) ARRAB9ASMN1; SMN2NPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219893-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease US GOV VETERANS AFFAIRS (US) 2023-07-13 US disclosed
US-11643394-B2 Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-05-09 US disclosed
US-20210347734-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK 2021-11-11 US disclosed
WO-2021222637-A1 KRÜPPEL-LIKE FACTOR 15 (KLF15) SMALL MOLECULE AGONISTS IN KIDNEY DISEASE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11643394-B2 Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease KIF15, KLF5, KLF10 NOX1 4531/4885AR 871/4885MAPT 43/4885
US-20230219893-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease KIF15, KLF5, KLF10 NOX1 4531/4885AR 871/4885MAPT 43/4885
US-20210347734-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease KIF15, KLF5, KLF10 NOX1 4531/4885AR 871/4885MAPT 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.